← FDA DRUG APPROVALS

FDA NDA · NDA016911

DELALUTIN

Sponsor: BRISTOL MYERS SQUIBB

APPLICATION
NDA016911
TYPE
NDA
ROUTE
INTRAMUSCULAR
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

DELALUTIN · ReferenceDiscontinued
HYDROXYPROGESTERONE CAPROATE 250MG/ML (250MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · SOLUTION · INTRAMUSCULAR
DELALUTIN · ReferenceDiscontinued
HYDROXYPROGESTERONE CAPROATE 125MG/ML (125MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · SOLUTION · INTRAMUSCULAR
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →